Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Importance of Albumin Infusion Rate for Plasma Volume Expansion. AIR. A Phase III Assessor Blinded Parallel Group Randomized Study

NCT02728921 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT02728921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Importance of Albumin Infusion Rate for Plasma Volume Expansion. AIR. A Phase III Assessor Blinded Parallel Group Randomized Study
Lead sponsor
Region Skane
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
November 30, 2016
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypovolemia, pancreatic neoplasms, systemic inflammatory response syndrome, urogenital neoplasm